newsfilter
← Latest News
GlobeNewswire·

Cocrystal Pharma's Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference

BOTHELL, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ:COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health